Eye News and Research

Latest Eye News and Research

Genetic study may help develop potential treatment strategies for stiff skin syndrome

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about scleroderma, a condition affecting about one in 5,000 people that leads to hardening of the skin as well as other debilitating and often life-threatening problems.

20 Mar 2010

Prevent Blindness America, Real Kids Shades partner to promote children's eye protection

In an effort to educate parents about the need to protect children's eye health, Prevent Blindness America, the nation's leading volunteer eye health and safety organization, and Real Kids Shades a leading manufacturer of quality eyewear for infants and children, are teaming up to ensure that 5 million children have healthy eyes for healthy futures. The joint effort supports "Star Pupils," a national program of Prevent Blindness America designed to arm parents with the information they need to help their children achieve a lifetime of healthy vision.

19 Mar 2010

OXiGENE reports audited financial statements for fiscal year ended December 31, 2009

OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.

19 Mar 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps). A second study examined endoscopist experience using TER and its impact on polyp detection rates, concluding that polyp detection rates improved significantly with TER.

19 Mar 2010

Bausch + Lomb ReNu MultiPlus multi-purpose solution named "Best Eye Care Product of the Year - Asia"

Bausch + Lomb ReNu MultiPlus(R) multi-purpose solution has been named "Best Eye Care Product of the Year - Asia" for its revolutionary bottle design at this year's A.S. Watson Global Suppliers Awards. Held in Hong Kong on 4 March 2010, the awards recognize international brands for outstanding performance in bringing innovation, differentiation and excitement to the consumer experience.

19 Mar 2010

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.

19 Mar 2010

Stiff skin syndrome cause found

18 Mar 2010

ISCO commences second phase of testing RPE derived from parthenogenetic stem cells

International Stem Cell Corporation, announced today that ISCO's Research and Therapeutic Development Group, together with a group of scientists from the University of California, Irvine (UCI), is starting a second phase of essential pre-clinical experiments to test retinal pigment epithelium derived from parthenogenetic stem cells. Follow on pre-clinical experiments will be conducted to rescue vision in disease models.

18 Mar 2010

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Manitobans with wet age-related macular degeneration (AMD) received a dose of good news. The Manitoba government announced that Lucentis (ranibizumab injection) will soon be funded through a centralized vision program, effective June 1, 2010.

18 Mar 2010

Academic Inventors’ Bill of Rights unveiled in poster presentation at AUTM Annual Meeting

As technology transfer managers from around the country prepare today to debate the role of academic researchers in commercializing their own inventions, two experts – one from each side of the aisle – have come together to propose an Academic Inventors’ Bill of Rights.

18 Mar 2010

Scientific revelations discovered during Retina Implant’s first human clinical trial

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company’s first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company’s expectations for their first trial.

18 Mar 2010

House Democratic leader twisting arms of the rank-and-file; Tracking health reform vote tally

Democrats are pressuring fellow members to accept the health care reform legislation and are playing hardball to secure votes for the health reform package.

18 Mar 2010

Acucela, Otsuka Pharmaceutical granted FDA Fast Track designation for ACU-4429 in treatment of dry AMD

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).

17 Mar 2010

First Edition: March 17, 2010

Today's news continues to focus on Democratic leaders' efforts to finalize their health reform package and gather the votes necessary to gain House passage.

17 Mar 2010

Researchers develop new analytical method to process large amounts of information faster

Researchers at North Carolina State University have developed a new analytical method that opens the door to faster processing of large amounts of information, with applications in fields as diverse as the military, medical diagnostics and homeland security.

17 Mar 2010

OVD issue highlights prevalence of eye problems in general population

In the latest issue of Optometry & Vision Development (OVD), Dr. Dominick Maino, editor of OVD, notes that: "In 2010 there are 9 million people with lazy eye and 18 million individuals with eye-turns

17 Mar 2010

Promedior raises $12M in Series C financing

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.

16 Mar 2010

Perrigo introduces generic Zaditor

Perrigo Company today announced that it has begun shipping Ketotifen Fumarate ophthalmic solution, 0.025%, a generic version of Zaditor™.

15 Mar 2010

Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis

Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.

15 Mar 2010

OXiGENE signs definitive agreement to sell Common Stock

OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has entered into a definitive agreement with certain institutional investors to sell 6,578,945 shares of its Common Stock and separate series of warrants to purchase Common Stock in a private placement.

12 Mar 2010

Eye News and Research

Latest Eye News and Research

Genetic study may help develop potential treatment strategies for stiff skin syndrome

Prevent Blindness America, Real Kids Shades partner to promote children's eye protection

OXiGENE reports audited financial statements for fiscal year ended December 31, 2009

Studies reveal increased polyp detection rates with TER during colonoscopy

Bausch + Lomb ReNu MultiPlus multi-purpose solution named "Best Eye Care Product of the Year - Asia"

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Stiff skin syndrome cause found

ISCO commences second phase of testing RPE derived from parthenogenetic stem cells

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Academic Inventors’ Bill of Rights unveiled in poster presentation at AUTM Annual Meeting

Scientific revelations discovered during Retina Implant’s first human clinical trial

House Democratic leader twisting arms of the rank-and-file; Tracking health reform vote tally

Acucela, Otsuka Pharmaceutical granted FDA Fast Track designation for ACU-4429 in treatment of dry AMD

First Edition: March 17, 2010

Researchers develop new analytical method to process large amounts of information faster

OVD issue highlights prevalence of eye problems in general population

Promedior raises $12M in Series C financing

Perrigo introduces generic Zaditor

Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis

OXiGENE signs definitive agreement to sell Common Stock

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Eye News and Research

Latest Eye News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in